High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor-dependent MCAT motif

Tomas Hucl, Jonathan R. Brody, Eike Gallmeier, Christine A. Iacobuzio-Donahue, Iain K. Farrance, Scott E. Kern

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor-dependent MCAT motif'. Together they form a unique fingerprint.

Medicine & Life Sciences